Industrial - Machinery
Compare Stocks
2 / 10Stock Comparison
EMR vs AME
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
EMR vs AME — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $79.02B | $53.72B |
| Revenue (TTM) | $18.32B | $7.60B |
| Net Income (TTM) | $2.44B | $1.53B |
| Gross Margin | 52.7% | 36.6% |
| Operating Margin | 19.8% | 26.2% |
| Forward P/E | 21.7x | 29.1x |
| Total Debt | $13.76B | $2.28B |
| Cash & Equiv. | $1.54B | $458M |
EMR vs AME — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| AMETEK, Inc. (AME) | 100 | 255.7 | +155.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EMR vs AME
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EMR is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 37 yrs, beta 1.52, yield 1.5%
- Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
- Lower P/E (21.7x vs 29.1x)
AME carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 423.4% 10Y total return vs EMR's 206.6%
- Lower volatility, beta 0.93, Low D/E 21.5%, current ratio 1.06x
- PEG 2.60 vs EMR's 4.81
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.6% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (21.7x vs 29.1x) | |
| Quality / Margins | 20.1% margin vs EMR's 13.3% | |
| Stability / Safety | Beta 0.93 vs EMR's 1.52, lower leverage | |
| Dividends | 1.5% yield, 37-year raise streak, vs AME's 0.5% | |
| Momentum (1Y) | +38.9% vs EMR's +30.4% | |
| Efficiency (ROA) | 9.6% ROA vs EMR's 5.8%, ROIC 12.1% vs 8.2% |
EMR vs AME — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EMR vs AME — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AME leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EMR is the larger business by revenue, generating $18.3B annually — 2.4x AME's $7.6B. AME is the more profitable business, keeping 20.1% of every revenue dollar as net income compared to EMR's 13.3%. On growth, AME holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $18.3B | $7.6B |
| EBITDAEarnings before interest/tax | $4.7B | $2.3B |
| Net IncomeAfter-tax profit | $2.4B | $1.5B |
| Free Cash FlowCash after capex | $3.1B | $1.7B |
| Gross MarginGross profit ÷ Revenue | +52.7% | +36.6% |
| Operating MarginEBIT ÷ Revenue | +19.8% | +26.2% |
| Net MarginNet income ÷ Revenue | +13.3% | +20.1% |
| FCF MarginFCF ÷ Revenue | +17.0% | +22.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | +11.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +28.2% | +14.5% |
Valuation Metrics
EMR leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 34.9x trailing earnings, EMR trades at a 5% valuation discount to AME's 36.6x P/E. Adjusting for growth (PEG ratio), AME offers better value at 3.28x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $79.0B | $53.7B |
| Enterprise ValueMkt cap + debt − cash | $91.2B | $55.5B |
| Trailing P/EPrice ÷ TTM EPS | 34.92x | 36.64x |
| Forward P/EPrice ÷ next-FY EPS est. | 21.71x | 29.08x |
| PEG RatioP/E ÷ EPS growth rate | 7.73x | 3.28x |
| EV / EBITDAEnterprise value multiple | 18.07x | 29.55x |
| Price / SalesMarket cap ÷ Revenue | 4.39x | 7.26x |
| Price / BookPrice ÷ Book value/share | 3.94x | 5.10x |
| Price / FCFMarket cap ÷ FCF | 29.63x | 32.14x |
Profitability & Efficiency
AME leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
AME delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $12 for EMR. AME carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to EMR's 0.68x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +12.1% | +14.4% |
| ROA (TTM)Return on assets | +5.8% | +9.6% |
| ROICReturn on invested capital | +8.2% | +12.1% |
| ROCEReturn on capital employed | +10.0% | +15.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.68x | 0.21x |
| Net DebtTotal debt minus cash | $12.2B | $1.8B |
| Cash & Equiv.Liquid assets | $1.5B | $458M |
| Total DebtShort + long-term debt | $13.8B | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | 6.46x | 23.34x |
Total Returns (Dividends Reinvested)
AME leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AME five years ago would be worth $17,454 today (with dividends reinvested), compared to $15,945 for EMR. Over the past 12 months, AME leads with a +38.9% total return vs EMR's +30.4%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.7% vs AME's 18.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +4.3% | +12.3% |
| 1-Year ReturnPast 12 months | +30.4% | +38.9% |
| 3-Year ReturnCumulative with dividends | +75.9% | +64.1% |
| 5-Year ReturnCumulative with dividends | +59.5% | +74.5% |
| 10-Year ReturnCumulative with dividends | +206.6% | +423.4% |
| CAGR (3Y)Annualised 3-year return | +20.7% | +18.0% |
Risk & Volatility
AME leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AME is the less volatile stock with a 0.93 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AME currently trades 96.4% from its 52-week high vs EMR's 85.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.52x | 0.93x |
| 52-Week HighHighest price in past year | $165.15 | $243.18 |
| 52-Week LowLowest price in past year | $108.37 | $168.49 |
| % of 52W HighCurrent price vs 52-week peak | +85.4% | +96.4% |
| RSI (14)Momentum oscillator 0–100 | 61.3 | 63.3 |
| Avg Volume (50D)Average daily shares traded | 2.8M | 1.2M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates EMR as "Buy" and AME as "Buy". Consensus price targets imply 14.8% upside for EMR (target: $162) vs 4.9% for AME (target: $246). For income investors, EMR offers the higher dividend yield at 1.49% vs AME's 0.53%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $161.92 | $245.91 |
| # AnalystsCovering analysts | 41 | 29 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +0.5% |
| Dividend StreakConsecutive years of raises | 37 | 16 |
| Dividend / ShareAnnual DPS | $2.10 | $1.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | +0.8% |
AME leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMR leads in 2 (Valuation Metrics, Analyst Outlook).
EMR vs AME: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is EMR or AME a better buy right now?
For growth investors, AMETEK, Inc.
(AME) is the stronger pick with 6. 6% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Emerson Electric Co. (EMR) offers the better valuation at 34. 9x trailing P/E (21. 7x forward), making it the more compelling value choice. Analysts rate Emerson Electric Co. (EMR) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EMR or AME?
On trailing P/E, Emerson Electric Co.
(EMR) is the cheapest at 34. 9x versus AMETEK, Inc. at 36. 6x. On forward P/E, Emerson Electric Co. is actually cheaper at 21. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AMETEK, Inc. wins at 2. 60x versus Emerson Electric Co. 's 4. 81x.
03Which is the better long-term investment — EMR or AME?
Over the past 5 years, AMETEK, Inc.
(AME) delivered a total return of +74. 5%, compared to +59. 5% for Emerson Electric Co. (EMR). Over 10 years, the gap is even starker: AME returned +423. 4% versus EMR's +206. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EMR or AME?
By beta (market sensitivity over 5 years), AMETEK, Inc.
(AME) is the lower-risk stock at 0. 93β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 63% more volatile than AME relative to the S&P 500. On balance sheet safety, AMETEK, Inc. (AME) carries a lower debt/equity ratio of 21% versus 68% for Emerson Electric Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — EMR or AME?
By revenue growth (latest reported year), AMETEK, Inc.
(AME) is pulling ahead at 6. 6% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to 7. 9% for AMETEK, Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EMR or AME?
AMETEK, Inc.
(AME) is the more profitable company, earning 20. 0% net margin versus 12. 7% for Emerson Electric Co. — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AME leads at 26. 2% versus 19. 6% for EMR. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EMR or AME more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, AMETEK, Inc. (AME) is the more undervalued stock at a PEG of 2. 60x versus Emerson Electric Co. 's 4. 81x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Emerson Electric Co. (EMR) trades at 21. 7x forward P/E versus 29. 1x for AMETEK, Inc. — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 8% to $161. 92.
08Which pays a better dividend — EMR or AME?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 5% for AMETEK, Inc. (AME).
09Is EMR or AME better for a retirement portfolio?
For long-horizon retirement investors, AMETEK, Inc.
(AME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), 0. 5% yield, +423. 4% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AME: +423. 4%, EMR: +206. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EMR and AME?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.